Delivery Order SPE2DB22D3501-SPE2DB26FTL24
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,833.50 on October 23, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a completion date of October 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under the company's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Zepbound 7.5 mg/0.5 mL pen injections valued at $10,966.72. The order was awarded on November 3, 2025, on a firm fixed-price basis with an ultimate completion date of November 4, 2025, with no set-aside designation applied. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,960.14 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,339.27 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 1, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,268.06 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.45 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, which is non-set-aside and competitively awarded under firm fixed-price terms, will be performed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.64 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on June 6, 2025, with a completion date of June 9, 2025. This competitively awarded, firm fixed-price contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $15,472.34. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $22,877.40 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,690.57 and an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL24Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,721.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract history demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This specific delivery order for Zepbound, a diabetes medication, reflects the company's ongoing role in supplying specialized pharmaceutical commodities to support Defense Health Agency and other government healthcare program requirements through flexible contract vehicles designed to serve military medical supply chains globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 11/7/25 |